Previous Article | Next Article ![]()
Infection and Immunity, November 2003, p. 6256-6263, Vol. 71, No. 11
0019-9567/03/$08.00+0 DOI: 10.1128/IAI.71.11.6256-6263.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
Department of Veterinary and Biomedical Sciences, University of Nebraska, Lincoln, Nebraska 68583
Received 2 May 2003/ Returned for modification 14 July 2003/ Accepted 23 July 2003
|
|
|---|
|
|
|---|
Since bacteria are efficient organisms, they express only the genes needed to survive and replicate under specific growth conditions (13, 28, 29). We have recently shown that the frequency of coiling phagocytosis in monocytes increases after intracellular growth in amoebae, suggesting that the genes involved are downregulated on standard laboratory media (7, 8). This information has been used to identify L. pneumophila entry loci through overexpression in wild-type bacteria (10). These studies resulted in the identification of three loci, enh1, enh2, and enh3, that play a role in entry by L. pneumophila into host cells. The rtxA and enhC genes, present in the enh1 and enh2 loci, respectively, have been shown to play a role in entry but when mutated only reduce uptake by approximately 50% (10). Despite this relatively moderate effect in in vitro assays, rtxA plays a critical role in the virulence of L. pneumophila during mouse infections (9). These data suggest that host cell infection by L. pneumophila is a complex process involving a large number of genes and that the genes involved can play an important role in pathogenesis despite having only moderate effects in in vitro virulence models.
In order to obtain a more comprehensive picture of the mechanisms that L. pneumophila uses to infect host cells, we wished to identify more of the genes involved in this process. Since overexpression by gene dosage effects was previously successful for the identification of L. pneumophila entry loci (10), we applied a similar strategy to identify additional genes. A constitutive promoter upstream of random fragments of the L. pneumophila genome was used for construction of a comprehensive expression library. Wild-type L. pneumophila organisms that carry this library can be screened for mutants that display an enhanced ability to infect host cells. We describe the use of this system to identify a locus that, when expressed from a constitutive promoter, enhances host cell infection by L. pneumophila. Mutagenesis and complementation analyses in wild-type bacteria demonstrate that this gene, lvhB2, plays an important role in adherence, entry, and intracellular replication by L. pneumophila when grown at 30°C. This gene is similar to the structural pilin subunit genes of type IV secretion systems and has been previously observed by other investigators (39). These studies support an important role for lvhB2 in the efficiency of L. pneumophila infection of host cells.
|
|
|---|
ec47 has been described previously (10) and was used to propagate plasmids containing an R6K origin of replication. DNA manipulations were done essentially as described previously (37). XL-1 Blue and
ec47 electroporation-competent cells were prepared and frozen as described previously (10, 14). |
View this table: [in a new window] |
TABLE 1. Bacterial strains and plasmids
|
Library construction. An L. pneumophila total genomic DNA library was constructed in the vector pWKS130 (43). For this library, L. pneumophila genomic DNA was isolated as described previously (10), partially digested with Sau3AI to obtain fragments ranging in length from 0.5 to 2.5 kbp, and ligated into the BamHI site of pWKS130. Plasmid DNA from pools of greater than 5,000 E. coli colonies was then separately transformed into L. pneumophila by electroporation as described previously (10, 14). Six pools of greater than 5,000 L. pneumophila clones (total of 30,000 clones) were enriched for enhanced host cell infection variants using entry assays.
Standard entry assays. The ability of L. pneumophila to infect host cells was evaluated using standard entry assays, which were carried out as described previously (10). Briefly, 106 HL-60 cells were differentiated in 24-well tissue culture dishes with 100 ng of phorbol 12-myristate 13-acetate (PMA; Sigma)/ml for 48 h prior to use. Nonadherent cells were removed by washing with phosphate-buffered saline (PBS), and 1 ml of culture medium was added. HEp-2 cells were seeded in 24-well dishes at a concentration of 1.5 x 105 cells/ml 18 to 24 h before use. A ratio of 10 bacteria per cell was added to each well and incubated for 30 min with monocytic cells or for 90 min with epithelial cells. All infections were carried out at 37°C. Cells were washed two times with PBS, and fresh medium containing 100 µg of gentamicin/ml was added to kill extracellular bacteria. After 2 h at 37°C, the cells were washed with PBS and lysed with sterile water, and dilutions were plated for CFU determinations. Entry levels were determined by calculating the percentage of the inoculum that became gentamicin resistant over the course of the assay [i.e., percent entry = 100 x (CFU gentamicin resistant/CFU of inoculum)]. To correct for variations in the levels of uptake between experiments, entry is reported relative to that of the wild-type strain (i.e., relative entry = percent entry of test strain/percent entry of wild type).
Enrichment for enhanced host cell infection clones. Pools of clones from the expression library were enriched for enhanced host cell infection variants in modified entry assays. Entry assays for enrichment of enhanced host cell infection variants were carried out in HEp-2 cells in the same manner as standard entry assays, except that bacteria were coincubated with cells for 5 min prior to the addition of gentamicin. Individual colonies that resulted from the subsequent plating for CFU were then screened individually for an enhanced entry phenotype relative to wild type in standard entry assays.
Adherence assays. Adherence assays were carried out by two methods, immediate assays (7-9) and formaldehyde assays (9, 16, 21), both of which have been described in detail previously. For immediate assays, HEp-2 and HL-60 cells were seeded and prepared as described for entry assays. After adding the bacteria at a ratio of 10 bacteria per cell, the medium was gently mixed by rocking back and forth, immediately washed five times with PBS to remove nonadherent bacteria, and then lysed by incubation for 10 min in 1 ml of water followed by vigorous pipetting. After lysis, the number of cell-associated bacteria was determined by plating for CFU on BCYE. Adherence assays on formaldehyde-fixed cells were carried out in the same manner except that the cells were fixed in 3.7% formaldehyde for 10 min, washed three times with PBS, and suspended in RPMI prior to addition of the bacteria. The bacteria were coincubated with the cells for 30 min (HL-60) or 90 min (HEp-2). Adherence levels were determined by calculating the percentage of the inoculum that became cell associated over the course of the assay [i.e., percent adherence = 100 x (CFU cell associated/CFU in inoculum)]. In order to correct for variation in levels of uptake between experiments, adherence is reported relative to that of wild-type strain AA100 at 37°C (i.e., relative adherence = percent adherence of test strain/percent adherence of AA100 at 37°C).
Intracellular growth assays. The growth kinetics of 30°C- and 37°C-grown L. pneumophila in PMA-differentiated HL-60 cells at 37°C was determined as described previously (7, 8). Briefly, bacteria were added to a monolayer of 106 cells/well of HL-60 cells in 24-well tissue culture dishes at a multiplicity of infection of 0.1 and incubated for 30 min at 37°C. Extracellular bacteria were killed by gentamicin treatment for 2 h, the cells were washed twice, and one set of triplicate wells was lysed with water and another set of wells was incubated in fresh medium at 37°C for 72 h before lysis in water. Dilutions of the lysate were plated to determine the CFU present. Survival is expressed as the portion of CFU present at 72 h compared to time zero (T0 = 2.5 h), i.e., mean (CFU T72/ T0) x 100.
Microscopy techniques. Adherence and entry levels were confirmed through examination of stained coverslips by fluorescence microscopy. We differentially stained intracellular and extracellular bacteria to allow discrimination between adherence and uptake. Intracellular and extracellular bacteria were differentially stained by first prestaining the bacteria prior to infection of cells followed by antibody detection of extracellular bacteria (without permeabilizing the cells) with polyclonal anti-L. pneumophila antibody. The rabbit polyclonal anti-L. pneumophila antibody was prepared and tested as described previously (8). This procedure allows intracellular bacteria to appear green and extracellular bacteria to stain both green and red by fluorescence microscopy. Basically, L. pneumophila cells were prestained with Oregon green (OG) prior to infection in a similar manner to that previously described using fluorescein (18, 47). The bacteria were suspended in PBS plus 5 µg of OG/ml, incubated at 30 or 37°C (depending on the prior growth temperature) for 30 min, and washed five times to remove unbound OG. Stained bacteria were then used to infect cells in the same manner as for standard entry assays, except that no gentamicin incubation was used. After washing, the monolayers were fixed with 2% paraformaldehyde in PBS for 1 h at 4°C followed by staining with primary and secondary antibody as described previously (8), except that the secondary antibody was conjugated with R-phycoerythrin (Becton Dickinson). Dual images of multiple fields were captured using an Optronics charge-coupled device video camera. The OG staining procedure did not affect bacterial viability (data not shown) or the ability of L. pneumophila to adhere to or enter into HL-60 or HEp-2 cells (data not shown). Viability of the labeled bacteria was confirmed using the LIVE-DEAD assay (Molecular Probes, Eugene, Oreg.) and by plating dilutions for CFU on BCYE agar (Difco).
DNA sequence analysis. DNA sequencing was performed as described previously (10) using a BigDye Terminator (Applied Biosystems) cycle sequencing apparatus and subsequent analysis on an ABI 310 automated sequencing apparatus (Applied Biosystems). Sequence analysis and assembly were carried out using Gene Construction Kit 2 (Textco), searches for homologous sequences were done using BLAST (1), and protein alignments were made using MegAlign (DNASTAR).
Construction of
lvhB2 and complementation.
An in-frame deletion in the coding region of lvhB2 was constructed by overlapping PCR as described previously (10). In this construct, the entire LvhB2 coding region was deleted with the exception of the ATG and TGA codons. The resulting PCR product has approximately 1 kbp of DNA flanking the lvhB2 start and stop codons and was cloned into the NotI site of pJDC15 (10). The resulting plasmid was transformed into L. pneumophila, and allelic exchange selected for sucrose and kanamycin as negative and positive selectable markers, respectively, as described previously (10). The presence of the appropriate deletion in the resulting lvhB2 mutant strain (
lvhB2) was confirmed by Southern and PCR analyses (data not shown). The complementing plasmid for lvhB2, pJDC38, was constructed using restriction digestion of L34 to delete all potential coding regions other than lvhB2. The resulting plasmid was then transformed into
lvhB2 and tested for complementation of the entry phenotype.
Statistical analyses. All in vitro experiments were carried out in triplicate and repeated at least three times. The significance of the results was analyzed using analysis of variance. P values of <0.05 were considered significant.
Nucleotide sequence accession number. The GenBank accession number for the nucleotide sequence of lvhB2 and the surrounding chromosomal region from L. pneumophila strain AA100 is AF410854.
|
|
|---|
We examined the phenotype of individual clones from the L. pneumophila expression library before and after enrichment. Prior to enrichment, 40 random clones were screened in standard entry assays and compared to wild-type L. pneumophila. None of the preenrichment clones displayed higher levels of entry into host cells than wild type (data not shown). After enrichment, two clones (5%), designated L1 and L34, out of 35 displayed at least twofold-enhanced entry into HEp-2 cells (data not shown) compared to that into the wild type (P < 0.01). In order to characterize the positive clones identified with this approach, plasmids were isolated from them and retransformed into wild-type L. pneumophila cells and the host cell infection phenotype of the resulting transformants was examined. All of the resulting retransformed clones displayed the enhanced host cell infection phenotype of the original clone (data not shown). These data suggest that the plasmids carrying L. pneumophila chromosomal fragments, rather than secondary mutations elsewhere in the chromosome, are responsible for the observed phenotype.
Analysis of clone L34. Restriction analysis of the clones that display an enhanced host cell infection phenotype, L1 and L34, with PstI, KpnI, and NheI demonstrated that they have identical physical maps (data not shown). A series of deletions were constructed in L34 to dissect the region responsible for the enhanced host cell infection phenotype (Fig. 1). We found that an internal PstI-NheI fragment is needed for the enhanced host cell infection phenotype conferred by the L34 plasmid (Fig. 2). In addition, neither portion of the L34 plasmid insert to the left (pJDC53) or right (pJDC52) of the KpnI restriction site conferred enhanced host cell infection alone, suggesting that the KpnI restriction site interrupts an open reading frame (ORF) that is necessary for the phenotype conferred by this plasmid. The L. pneumophila chromosomal DNA insert in the L34 plasmid was sequenced and found to contain an ORF encoding a putative protein of 96 amino acids in length that is interrupted by digestion with KpnI. This ORF is in the proper orientation to allow expression from the pWKS130 Ptac promoter. We initially designated this gene enhD to indicate that it has the ability to confer enhanced host cell infection. This gene has recently been sequenced in another strain of L. pneumophila, where it was designated lvhB2 and part of a large putative operon involved in type IV secretion (39). Although the lvh operon appears to play a role in conjugation, its role in virulence has not been investigated.
![]() View larger version (15K): [in a new window] |
FIG. 1. Constructs derived from enhanced entry clone L34 and structures of the lvh region in wild-type (AA100) and the lvhB2 in-frame deletion ( lvhB2) mutant L. pneumophila. The chromosomal region surrounding lvhB2 encodes a large putative operon in the wild-type strain. The structure of the in-frame deletion in the lvhB2 coding region is shown above the lvhB2 construct. Arrows indicate putative coding regions and the direction of transcription. All constructs are drawn to scale (L34 is 5.7 kbp) except the wild-type and lvhB2 chromosomal regions, which are scaled relative to each other (the AA100 lvh region is 13.1 kbp).
|
![]() View larger version (31K): [in a new window] |
FIG. 2. Ability of L34 and the various deletions in this construct to confer enhanced entry into HEp-2 cells by L. pneumophila. Entry of the wild-type strain (AA100) was arbitrarily set to 1. Data points and error bars represent the means and standard deviations, respectively, of assays done in triplicate. Results shown are for a typical experiment.
|
![]() View larger version (71K): [in a new window] |
FIG. 3. Alignment of LvhB2 with other similar bacterial pilin proteins. Conserved amino acid residues are shown in filled boxes. Numbers to the right of the alignment indicate the amino acid position within the protein. The putative signal peptidase cleavage site is indicated by an arrow above the alignment. Abbreviations for aligned proteins and their accession numbers are as follows: LpLvhB2, L. pneumophila LvhB2 (AF410854); BsVirB2, Brucella suis VirB2 (AAD56612); BpPtlA, B. pertussis PtlA (AAB27428); BhVirB2, Bartonella henselae VirB2 (AAD48919); AtVirB2, Agrobacterium tumefaciens VirB2 (AAB28331); pKM101TraM, plasmid pKM101 TraM (I79265); R388TrwM, plasmid R388 TrwM (BAB12656); RP4TrbC, plasmid RP4 TrbC (AAA26429); FTraA, F plasmid TraA (NP_061453); SmVirB2, Sinorhizobium meliloti VirB2 (AAK65376); XfVirB2, Xylella fastidiosa VirB2 (NP_061661).
|
lvhB2) in this gene to prevent polar effects on downstream genes (Fig. 1). This construct carries a complete in-frame deletion in the LvhB2 coding region, producing an ORF that encodes only the translational start and stop codons for this protein. An L. pneumophila strain carrying this mutation was constructed by allelic exchange using sucrose as a counterselectable marker and confirmed by Southern and PCR analyses (data not shown). We found that the lvhB2 mutant does not display a significant defect in the ability to infect human monocytic or epithelial cell lines when grown at 37°C (Fig. 4A and B). This observation suggests that either this gene plays no role in host cell infection or it is not expressed well at higher temperatures under standard laboratory growth conditions unless it is expressed from an exogenous promoter. This is the case for the L34 construct, where the gene is downstream of the Ptac promoter.
![]() View larger version (48K): [in a new window] |
FIG. 4. Entry of L. pneumophila wild type (AA100) and lvhB2 in-frame deletion ( lvhB2) with the vector alone (AA100::pWKS130 lvhB2::pWKS130) or the vector containing lvhB2 (AA100::pJDC38 lvhB2::pJDC38) at 37°C into the epithelial (A and C) or monocytic (B and D) cell line after growth of the bacteria at 37°C (A and B) or 30°C (C and D). Entry of the wild-type strain was arbitrarily set to 1. Data points and error bars represent the means and standard deviations, respectively, of assays done in triplicate. Results shown are for a typical experiment.
|
100-fold reduced in entry compared to wild type (Fig. 4C and D). This defect in the ability to infect host cells is complemented by the presence of vector containing only the L. pneumophila lvhB2 gene (pJDC38). Since all host cell infections were carried out at 37°C, this difference is likely due to changes in expression of lvhB2 at lower temperatures.
In order to confirm the difference in the ability of the lvhB2 mutant to infect host cells compared to wild-type L. pneumophila, we examined these infections by fluorescence microscopy. We used differential staining with fluorescent markers to determine whether the bacteria were intracellular or extracellular. All bacteria were first prestained with OG, and then only extracellular bacteria were labeled with a secondary antibody conjugated to R-phycoerythrin. This technique allows determination of the total number of cell-associated bacteria and whether they are adherent or intracellular and does not affect bacterial viability or their ability to enter into or adhere to host cells (data not shown). Similar to gentamicin protection assays, there is no apparent difference between the wild type and the
lvhB2 L. pneumophila mutant when the bacteria are grown at 37°C, but when grown at 30°C the
lvhB2 mutant displays obviously lower (P < 0.01) levels of cell association (Fig. 5). Since the staining technique used for microscopy should not be affected by bacterial viability, as would the CFU-based gentamicin protection assays, rapid killing by host cells following uptake is not solely responsible for the differences observed. The higher percentage of intracellular bacteria observed at 30°C with the monocytic cell line compared to the epithelial cell line is most likely the result of the constitutively phagocytic nature of monocytic cells. Based both on standard gentamicin protection assays for entry and microscopy, we found a significant defect in the ability of the L. pneumophila lvhB2 mutant to infect monocytic and epithelial cell lines.
![]() View larger version (20K): [in a new window] |
FIG. 5. Fluorescence microscopic quantitation of the number of bacteria and the proportion that are extracellular and intracellular per 100 cells for wild-type (AA100) and lvhB2 in-frame deletion ( lvhB2) mutant L. pneumophila strains grown at 37 and 30°C and infecting the epithelial (A) or monocytic (B) cell line. Fifty microscopic fields with greater than 10 cells per field were quantitated for each sample (>500 cells). Data points represent the means of assays done in triplicate. Results shown are for a typical experiment.
|
lvhB2 and wild-type L. pneumophila to epithelial and monocytic cell lines after growth of the bacteria at both 37 and 30°C (Fig. 6). To completely rule out the possibility that entry and/or intracellular killing were solely responsible for the data obtained, both standard immediate adherence assays and formaldehyde adherence assays, where internalization cannot occur, were used. Both assay methods have been previously shown to allow accurate measurement of adherence to host cells by L. pneumophila (9). Both the wild type and
lvhB2 mutant adhere better to epithelial and monocytic cell lines at 30°C than at 37°C (P < 0.01). Furthermore, the
lvhB2 mutant displays a defect in adherence at 30°C (P < 0.01) but adheres at the same levels as wild type at 37°C.
![]() View larger version (39K): [in a new window] |
FIG. 6. Adherence of wild-type (AA100), lvhB2 in-frame deletion ( lvhB2) mutant, and complemented mutant ( lvhB2::pJDC38) L. pneumophila strains grown at 37 and 30°C into the epithelial (A and C) or monocytic (B and D) cell line. Assays were carried out in either normal (A and B) or formaldehyde-fixed (C and D) cells. Adherence of the wild-type strain at 37°C was arbitrarily set to 1. Data points and error bars represent the means and standard deviations, respectively, of assays done in triplicate. Results shown are for a typical experiment.
|
![]() View larger version (25K): [in a new window] |
FIG. 7. Intracellular survival and replication of 37°C- (A) and 30°C- (B) grown L. pneumophila strain AA100 containing vector alone (AA100::pWKS130), the lvhB2 mutant containing the vector ( lvhB2::pWKS130), and the lvhB2 mutant containing the vector carrying lvhB2 ( lvhB2::pJDC38) in human HL-60 monocyte-derived macrophages over 72 h. Data points and error bars represent the means and standard deviations, respectively, of assays done in triplicate. Results shown are for a typical experiment.
|
|
|
|---|
The lvhB2 gene was identified by enriching for clones that display an enhanced ability to infect host cells from an L. pneumophila expression library. It is not surprising that this type of approach would be effective for the identification of L. pneumophila genes involved in host cell infection, because a similar strategy has been previously used to identify three other loci involved in this process (10). The primary difference between the present strategy and the previous one is that low-copy vectors carrying a constitutive promoter were used instead of a low-copy cosmid vector. Gene dosage effects were most likely responsible for the observed enhanced entry phenotype in our previous study, whereas gene dosage effects and constitutive expression may both contribute to the L34 enhanced host cell infection phenotype.
The putative protein product encoded by the lvhB2 gene is similar to the major pilin subunit for a type IV secretion system. Recently, a type IV secretion system has been implicated in the adherence and entry of Campylobacter jejuni (2), suggesting that this mechanism of host cell infection may be used by other bacterial pathogens. In Campylobacter, another component of the type IV secretion system, a VirB11 homologue, has been shown to be required for both adherence and entry. There are at least four VirB11 homologues in L. pneumophila: LvhB11 in the lvh region, DotB in the dot/icm region, PilB in pilin biosynthesis, and a fourth homologue within the type II secretion system (6, 40). These observations combined with the function of lvhB2 suggest that both the lvh region and dot/icm complex may play a role in the initial interactions of L. pneumophila with host cells. This hypothesis is supported by observations that the effects of the dot/icm complex on intracellular trafficking are seen very early during the interaction of L. pneumophila with monocytes (36, 47), and two of the dot genes, dotH and dotO, can affect the rate of bacterial internalization (44). A role for dot/icm in uptake by macropinocytosis has also been confirmed by two separate groups (24, 45). Since lvhB2 appears to play a role in entry primarily at lower temperatures, possibly the dot/icm complex is an alternative system used at higher growth temperatures. However, detailed studies on the temperature regulation of dot/icm and lvh and the interplay between them are necessary to better understand the roles of these distantly related L. pneumophila type IV secretion systems in host cell infection.
Previous studies in L. pneumophila found that the lvh and dot/icm complex are both involved in conjugation, and some of their components can substitute for each other in this event (39). The lvh region was not found to have a role in the interaction of L. pneumophila with monocytes, in contrast to the critical role of dot/icm in intracellular trafficking and survival. Since these experiments were carried out with bacteria grown at 37°C, they are fairly consistent with our data where a large effect on host cell infection was only observed when L. pneumophila was grown at 30°C. However, we also observed a small, but significant, effect on intracellular growth when the bacteria were grown at 37°C that was not observed in the previous studies. This small discrepancy is most likely due to the different genetic backgrounds of the wild-type strains used in the two studies. Our finding that temperature plays a role in the ability of L. pneumophila to infect host cells is consistent with previous observations that temperature regulates the expression of a type IV pilus in L. pneumophila that also plays a role in adherence (27, 41). Furthermore, temperature has been shown to play an important role in the regulation of flagellum expression (23, 32), and motility has been implicated in the ability of L. pneumophila to infect host cells (12). Three other loci have been identified that play a role in entry by L. pneumophila, but the effects of temperature on their regulation have not been examined (10). Investigation of temperature regulation of these and other L. pneumophila virulence genes should provide useful information regarding the array of genes that are coordinately expressed with lvhB2.
These studies have identified a gene, lvhB2, that affects the efficiency of host cell infection by L. pneumophila when the bacteria are grown at 30°C. This observation might suggest that temperature is important in the ability of L. pneumophila to infect mammalian cells. However, it is equally likely that this gene is primarily involved in the ability to infect organisms living in aquatic environments. A role for environmental temperature in natural L. pneumophila infections has been previously suggested by the fact that they arise after exposure to aerosols from domestic water systems (3, 4, 22), where the optimal growth temperature of the inoculating dose is unclear. Our data combined with the observation that other genes involved in motility and host cell adherence are expressed optimally at lower temperatures (32, 41) suggest that growth of L. pneumophila under these conditions may be relevant to natural infections. Alternatively, these genes may play a role only during infections of environmental hosts, aquatic protozoa. It is likely that genes expressed at temperatures lower than 37°C play an important role in the ability of L. pneumophila to survive and replicate in aquatic environments. However, the theory that these genes are only important in environmental hosts does not fit well with the fact that the lvh region, including lvhB2, is found primarily in Legionella isolates that are the most likely to cause disease in humans (38). Thus, further studies are necessary to evaluate whether temperature is an important regulatory signal for the ability of L. pneumophila to infect humans, environmental protozoa, or both. These studies should provide insight into the complex interplay between Legionella infections in humans and environmental reservoirs for this pathogen.
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»